Bioproduction Solutions from Molecule to Market

Each phase of bioprocessing is an opportunity to be more productive than your competition: from optimizing cell line titers, media formulations, and scaling cell culture production to same-day critical impurity analyses and reducing purification run times.

We are here to support you at every phase in your quest to go to market faster and smarter.  When you choose us as your trusted partner, you receive our trusted and high quality products, services, and support.

Worldwide distribution, service and support reach 150 countries on 6 continents

Manufacturing Excellence and Supply Chain Confidence

We strive to set new standards to provide manufacturing excellence and supply chain confidence for our customers.  From manufacturing and supplier risk mitigation, to site and process alignment, our processes promote organizational preparedness.

We understand our manufacturing capabilities and supply chain are an integral part of your bioproduction processes - responsibilities we take very seriously.

Dual Sources for AGT™ Dry Media Format

In order to help meet our customers’ risk mitigation requirements related to supply assurance and consistency, we have expanded our media manufacturing capabilities in Inchinnan, Scotland by constructing a new, state-of-the-art, animal origin-free (AOF) dry media manufacturing facility to provide a second source of AGT™ dry media format as well as traditional AOF Dry Powder Medium (DPM).  This expansion will not only increase our capacity, it provides us with a significant step forward in executing against our long term continuity plans.  As a result, operational processes, from order entry and creation of documentation, to conversion processes and testing are being aligned to provide our customers a supply stream of equivalent product through redundant sites, regardless of the site of manufacturing origin.

We are committed to high quality standards in media manufacturing for our global customers and meeting your specific requirements for confidence in your manufacturing processes.

Please click below to download a copy of our Media Continuity Planning letter, or contact Technical Service to learn more.

Manufacturing Sites

Grand Island, NY, United States
Cell culture media, reagents, and sera manufacturing

Auckland, New Zealand Sera and protein products manufacturing

Newcastle, Australia
Sera manufacturing

Sequencing and PCR instrument manufacturing

Vantaa, Finland
Pharma analytics instrument manufacturing

Hitachi, Japan 
Pharma analytics instrument manufacturing

Paisley, Scotland
Cell culture media and reagents

Christchurch, New Zealand
Protein products manufacturing

Bedford, MA, United States
Chromatography resins manufacturing

Warrington, England
Pharma analytics kit manufacturing

Austin, TX, United States 
Pharma analytics kit manufacturing


Contact us to schedule a site tour